Qinghai Spring Wholly-owned Subsidiary Receives Notice of “Administrative Penalty Decision”
Announcement regarding the violation of partial share repurchase by Qinghai Spring Medicinal Resources Technology.
Announcement from Qinghai Spring Medicinal Resources Technology regarding the risk warning of stock trading.
qinghai spring medicinal resources technology semi-annual report for 2024.
Qinghai Spring Medicinal Resources Technology Summary of the Semi-annual Report in 2024.
Announcement on Pledging of Part of Shareholding by the Controlling Shareholder of Qinghai Spring Medicinal Resources Technology
Reply to Inquiry Letter from Qinghai Spring Medicinal Resources Technology's Shareholder and Actual Controller.
Notice from Qinghai Spring Medicinal Resources Technology regarding abnormal fluctuations in stock trading.
Announcement from Qinghai Spring Medicinal Resources Technology regarding the risk warning of stock trading.
Reply to Inquiry Letter from Qinghai Spring Medicinal Resources Technology's Shareholder and Actual Controller.
Notice from Qinghai Spring Medicinal Resources Technology regarding abnormal fluctuations in stock trading.
Announcement on the implementation results of share repurchase and share changes by Qinghai Spring Medicinal Resources Technology
Announcement from Qinghai Spring Medicinal Resources Technology regarding the risk warning of stock trading.
Reply to Inquiry Letter from Qinghai Spring Medicinal Resources Technology's Shareholder and Actual Controller.
Notice from Qinghai Spring Medicinal Resources Technology regarding abnormal fluctuations in stock trading.
Revised Edition - Deloitte Certified Public Accountants (Special General Partnership) Special Explanation on Issuing Non-Standard Audit Opinion Report on the 2023 Financial Statements of Qinghai Spring Medicinal Resources Technology.
Special explanation on the issues that require the accountant to express opinions in the inquiry letter of Qinghai Spring Medicinal Resources Technology by Daxin Certified Public Accountants (Special General Partnership).
Qinghai Spring Medicinal Resources Technology's announcement regarding the reply to the Shanghai Stock Exchange's Information Disclosure Regulatory Inquiry Letter in the 2023 Annual Report.
Qinghai Spring Medicinal Resources Technology Correction Announcement on Performance Forecast for the First Half of 2024.
Qinghai Spring Medicinal Resources Technology's half-year performance forecast for 2024.
No Data
No Data